You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Gilteritinib with standard chemotherapy for newly diagnosed FLT3-mutation-positive acute myeloid leukaemia when intensive chemotherapy is suitable [TSID12331]
Awaiting development
Reference number:
GID-TA11936
Expected publication date: TBC
Project information
Project documents
Documents
Documents created during the development process.
Topic prioritisation
Topic prioritisation
Back to top